Skip to content

2023 Annual Report

  • Dorrit Walsh

We're pleased to share with you our latest Annual Report, which highlights everything we accomplished in 2023.

Read more

Treatment Action Group Calls on NY City Council to Override and Mayor Adams to Reverse Egregious Cuts to New York City HIV Funding

  • Dorrit Walsh

In response to disheartening news of the proposed $5.3 million cut in HIV/AIDS funding by the Adams administration, we at Treatment Action Group (TAG) express our resolute opposition, in solidarity with our partner organizations that would be harmed by the egregious, unconscionable cuts to HIV services and programs in New York City.

Read more

Director of Development

  • Dorrit Walsh

Treatment Action Group (TAG) seeks a dynamic, motivated, and skilled individual to become its Director of Development supporting the organization as it continues to grow.

Read more

Going Behind the Scenes at TAG

  • Dorrit Walsh

Follow along with one of our staff members on a typical day, and you'll see the difference you make as a TAG donor and partner.

Read more

Empowering Health, Parts 1 and 2

  • Dorrit Walsh

On May 7 and 21, TAG celebrated Pride season by hosting for an essential webinar that addressed the unique health concerns of the LGBTQ+ community, focusing on engaging LGBTQ patients.

Read more

Treatment Action Group Is Organizational Sponsor of SYNChronicity 2024

  • Dorrit Walsh

Treatment Action Group (TAG) is proud to be one of the organizational sponsors of SYNChronicity 2024 (SYNC 2024). This annual national conference for HIV, HCV, STIs, harm reduction, and LGBTQ health will be held in Arlington, Virginia, from May 29 – 31; more than 1500 attendees are expected to participate.

Read more

Research in Action Awards 2024

  • Dorrit Walsh

Save the Date: Thursday, October 17, 2024, when our Research in Action Awards return this fall! Once again we'll honor some of the most brilliant activists, scientists, and leaders in the fight to end HIV, tuberculosis (TB), and hepatitis C (HCV).

Read more
Back To Top